HIV SEROPOSITIVITY
Clinical trials for HIV SEROPOSITIVITY explained in plain language.
Never miss a new study
Get alerted when new HIV SEROPOSITIVITY trials appear
Sign up with your email to follow new studies for HIV SEROPOSITIVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New peptide aims to flush out hidden HIV in early trial
Disease control OngoingThis Phase 2 trial tests whether adding Gammora® (a peptide) to standard antiretroviral therapy can reduce the hidden HIV reservoir in people newly diagnosed with HIV. Forty participants who have never taken HIV drugs will be randomly assigned to receive either Gammora® plus stan…
Matched conditions: HIV SEROPOSITIVITY
Phase: PHASE2 • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to safely prevent TB in pregnant women with HIV
Disease control OngoingThis study is testing two tuberculosis (TB) prevention treatments in pregnant women who also have HIV. The goal is to see if these treatments are safe and how they interact with the HIV medication dolutegravir. About 252 pregnant women will take either a daily TB drug for one mon…
Matched conditions: HIV SEROPOSITIVITY
Phase: PHASE1, PHASE2 • Sponsor: The Aurum Institute NPC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a One-Month TB pill be as good as three? new trial tests shorter prevention
Prevention OngoingThis study tests whether taking two TB prevention drugs daily for one month works as well as taking them weekly for three months. It includes 1,000 people with HIV or those living with someone recently diagnosed with TB. The goal is to see which schedule more people complete and …
Matched conditions: HIV SEROPOSITIVITY
Phase: PHASE4 • Sponsor: The Aurum Institute NPC • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC